Return to Article Details
CONSTRUCT THE MODEL OF COST– EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB VERSUS STANDARD THERAPY IN THE TREATMENT OF MULTIPLE MYELOMA IN VIETNAM
Download
Download PDF